Bibliography 2005

Iodine excretion in regions of Ukraine affected by the Chornobyl Accident: experience of the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases.
Tronko M, Kravchenko V, Fink D, Hatch M, Turchin V, McConnell R, Shpak V, Brenner A, Robbins J, Lusanchuk I, Howe G.
Thyroid. 2005 Nov;15(11):1291-7.

Permanent hypoparathyroidism due to thyroid cancer surgical procedures in patients exposed to radiation in the Chernobyl, Ukraine, nuclear reactor accident.
Bohrer T, Pasteur I, Lyutkevych O, Fleischmann P, Tronko M.
Dtsch Med Wochenschr. 2005 Nov 4;130(44):2501-6. German. 

Chernobyl: poverty and stress pose 'bigger threat' than radiation.
Stephan V.
Nature. 2005 Sep 8;437(7056):181. 

Gene expression profiling in human thyroid tumors.
Maenhaut C.
Bull Mem Acad R Med Belg. 2004;159(10-12):533-9; discussion 539-40. French. 

Incidence of thyroid cancer in the population of the Bryansk Region after the Chernobyl nuclear plant accident.
Zvonova IA, Bramilova AA, Pochtennaia GT, Petrova GV.
Vopr Onkol. 2005;51(5):540-5. Russian.

Radiation-induced thyroid cancer--what's new?
Boice JD Jr.
J Natl Cancer Inst. 2005 May 18;97(10):703-5. Review. 

Risk of thyroid cancer after exposure to 131I in childhood.
Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D. 
J Natl Cancer Inst. 2005 May 18;97(10):724-32.

Uncertainty and sensitivity analysis in assessment of the thyroid cancer risk related to chernobyl fallout in eastern france.
Catelinois O, Laurier D, Verger P, Rogel A, Colonna M, Ignasiak M, Hemon D, Tirmarche M.
Risk Anal. 2005 Apr;25(2):243-52.

Absence of a specific radiation signature in post-Chernobyl thyroid cancers.
Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, Tronko MD, Dumont JE, Franc B, Thomas G, Maenhaut C.
Br J Cancer. 2005 Apr 25;92(8):1545-52.

ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients.
Di Cristofaro J, Vasko V, Savchenko V, Cherenko S, Larin A, Ringel MD, Saji M, Marcy M, Henry JF, Carayon P, De Micco C.
Endocr Relat Cancer. 2005 Mar;12(1):173-83.

Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma. 
Stephens LA, Powell NG, Grubb J, Jeremiah SJ, Bethel JA, Demidchik EP, Bogdanova TI, Tronko MD, Thomas GA. 
Thyroid. 2005 Feb;15(2):100-4.

Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.
Powell N, Jeremiah S, Morishita M, Dudley E, Bethel J, Bogdanova T, Tronko M, Thomas G. 
J Pathol. 2005 Apr;205(5):558-64.

Post-Chornobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses. 
Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Bouville A, Luckyanov N, Jacob P, Voilleque P, Voigt G. 
Radiat Res. 2005 Feb;163(2):125-36.

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. 
Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE.
J Clin Invest. 2005 Jan;115(1):94-101.

A new mechanism of BRAF activation in human thyroid papillary carcinomas. 
Fusco A, Viglietto G, Santoro M. 
J Clin Invest. 2005 Jan;115(1):20-3.